Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2005 Dec;43(12):6214. doi: 10.1128/JCM.43.12.6214.2005

Sequence Variant for Internal Transcribed Spacer Region of Mycobacterium abscessus

Haleina Neal 1, Joann L Cloud 1,*, June I Pounder 1, Sam R Page 1, Gail L Woods 1
PMCID: PMC1317224  PMID: 16333135

During the implementation of a PCR-based assay to differentiate between Mycobacterium abscessus and M. chelonae using the 16S to 23S internal transcribed spacer region (1), a sequence variant of M. abscessus was discovered. The sequence variant did not bind the M. abscessus specific probe, resulting in no or low fluorescence detected. The base change was found at position 39 of the amplicon (GenBank accession no. DQ177308). The base change was confirmed by sequencing with four additional patient isolates. A total of 6 isolates out of 129 tested from 3 March 2005 to 21 July 2005 had low fluorescence detected for a frequency of 4.65%.

The PCR assay has since been improved by redesigning the M. abscessus probe (Nanogen, Inc., Bothell, WA) to incorporate proprietary modified bases for more-efficient hybridization characteristics. The probe modification included incorporation of a super G (proprietary modified base G) at the site of the polymorphism as well as a super A (proprietary modified base A) further downstream (Table 1). The improved assay allowed for a detectable level of fluorescence for all isolates. The fluorescence detected in the FAM (6-carboxyfluorescein) channel on the SmartCycler II (Cepheid, Inc., Sunnyvale, CA) increased from an average of 41.7 ± 36 (range of 0 to 100) fluorescence units to 180 ± 22 (range of 150 to 200) fluorescence units.

TABLE 1.

New MGB Eclipse probe showing modification from the old probe

Probe Probe sequence
New probe MGB-quencher 5′AGTAGGG*ATCTGTA*GTGG3′ FAMa
Original probe MGB-quencher 5′AGTAGGCATCTGTAGTGG3′ FAM
a

G*, super G; A*, super A.

The assay with the modified probe performed with 100% sensitivity after testing 22 M. abscessus isolates, 6 of which were sequence variants, and 100% specificity after testing 10 M. chelonae isolates. All samples tested were proven by 16S rRNA gene sequencing to be among the M. chelonae-M. abscessus complex, as previously reported (1).

Acknowledgments

This study was funded by the ARUP Institute for Clinical and Experimental Pathology.

We thank Yevgeniy Belousov and Nanogen/Epoch Biosciences for the probe redesign.

REFERENCE

  • 1.Cloud, J. L., K. Hoggan, E. Belousov, S. Cohen, B. A. Brown-Elliott, L. Mann, R. Wilson, W. Aldous, R. J. Wallace, Jr., and G. L. Woods. 2005. Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J. Clin. Microbiol. 43:4205-4207. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES